Compare Nike Inc (NKE) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nike Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Nike Inc trades at $34.96 (market cap $51.04B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B). The key difference: Nike Inc is far larger — about 22.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Nike Inc pays a 4.77% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| NKE | SLS | |
|---|---|---|
Market Cap | $51.04B | $2.28B |
Volume | 37,567,242 | 3,128,960 |
Sector | Consumer Cyclical | Health |
52-Week High | $69.68 | $15.46 |
52-Week Low | $33.87 | $1.39 |
Typical Hold Time | 155 Days | — |
Enterprise Value | $53.74B | $2.15B |
Dividend Yield | 4.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nike (NKE) trades at $34.74, up 0.38% on the day, amid a bearish technical signal and mixed earnings history. The stock shows strong profitability with a 43.07% gross margin and 21.56% ROE, but revenue declined to $46.31B in 2025. Recent news highlights challenges in China and EMEA, while analysts maintain a $36.98 consensus target.
Nike's outlook hinges on executing its turnaround strategy to revive growth. Investment opportunities include brand strength and digital initiatives, but risks involve sluggish demand, margin pressure, and intense competition. The stock's valuation appears reasonable with a P/E of 16.44, yet near-term headwinds warrant caution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nike Inc
NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Read more on NKE →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
